The recently published data confirm the association of IL-17 with the MEGF11 gene (multiple epidermal growth factor like domains 11), whose expression is significantly higher in the tumor tissue of triple-negative breast cancer patients who experienced relapse (39). This evidence concerns the gene MEGF11 and triple-negative breast carcinoma.